Variant report
Variant | esv3327066 |
---|---|
Chromosome Location | chr7:27083652-27086200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:27085899-27085908 | HepG2 | liver: | n/a | n/a |
2 | FOS | chr7:27086117-27086846 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr7:27086133-27087114 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr7:27086170-27087128 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr7:27086119-27086830 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOXA2 | chr7:27083793-27084255 | A549 | lung: | n/a | n/a |
7 | GABPA | chr7:27085551-27085650 | Hela-S3 | cervix: | n/a | n/a |
8 | GATA2 | chr7:27085363-27085731 | K562 | blood: | n/a | n/a |
9 | NR2F2 | chr7:27085305-27085754 | K562 | blood: | n/a | n/a |
10 | NR2F2 | chr7:27085211-27085785 | K562 | blood: | n/a | n/a |
11 | NR3C1 | chr7:27085539-27085653 | A549 | lung: | n/a | n/a |
12 | PAX5 | chr7:27083648-27084051 | GM12878 | blood: | n/a | n/a |
13 | PAX5 | chr7:27083718-27084005 | GM12878 | blood: | n/a | n/a |
14 | PAX5 | chr7:27083688-27083988 | GM12878 | blood: | n/a | n/a |
15 | PAX5 | chr7:27083690-27084064 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr7:27085562-27085644 | A549 | lung: | n/a | n/a |
17 | REST | chr7:27085537-27085606 | U87 | brain: | n/a | n/a |
18 | REST | chr7:27084056-27084327 | PANC-1 | pancreas: | n/a | n/a |
19 | SP1 | chr7:27085349-27085611 | HepG2 | liver: | n/a | n/a |
20 | USF1 | chr7:27085547-27085655 | HepG2 | liver: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
NHP2P2 | TF binding region |
ENSG00000105991 | chromatin interactions |
ENSG00000106004 | chromatin interactions |
ENSG00000105997 | chromatin interactions |
ENSG00000254369 | chromatin interactions |
ENSG00000273433 | chromatin interactions |
ENSG00000233429 | chromatin interactions |
ENSG00000272801 | chromatin interactions |
ENSG00000106006 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs80225093 | chr7:27083683-27083684 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
2 | rs539670257 | chr7:27083698-27083699 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
3 | rs371029505 | chr7:27083702-27083703 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
4 | rs547874811 | chr7:27083703-27083704 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
5 | rs183888975 | chr7:27083717-27083718 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
6 | rs371608889 | chr7:27083722-27083723 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
7 | rs70994622 | chr7:27083741-27083742 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
8 | rs2428419 | chr7:27083748-27083749 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs555125361 | chr7:27083779-27083780 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
10 | rs575250047 | chr7:27083814-27083815 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
11 | rs10229631 | chr7:27083845-27083846 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
12 | rs564045042 | chr7:27083851-27083852 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
13 | rs577100981 | chr7:27083852-27083853 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
14 | rs10259123 | chr7:27083853-27083854 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
15 | rs369015776 | chr7:27083861-27083862 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
16 | rs570979498 | chr7:27083874-27083875 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
17 | rs373232609 | chr7:27083875-27083876 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
18 | rs112915853 | chr7:27083931-27083932 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
19 | rs530376693 | chr7:27083944-27083945 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
20 | rs528622233 | chr7:27083956-27083957 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
21 | rs554174769 | chr7:27083971-27083972 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
22 | rs542355572 | chr7:27084032-27084033 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
23 | rs562032348 | chr7:27084033-27084034 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
24 | rs530968250 | chr7:27084117-27084118 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
25 | rs6972488 | chr7:27084164-27084165 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
26 | rs369355058 | chr7:27084165-27084166 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
27 | rs192491482 | chr7:27084172-27084173 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
28 | rs373088936 | chr7:27084220-27084221 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
29 | rs550677407 | chr7:27084232-27084233 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
30 | rs527248862 | chr7:27084279-27084280 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
31 | rs376282037 | chr7:27084308-27084309 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
32 | rs541343033 | chr7:27084320-27084321 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
33 | rs570828911 | chr7:27084325-27084326 | Weak transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
34 | rs533279123 | chr7:27084349-27084350 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
35 | rs546872663 | chr7:27084385-27084386 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
36 | rs566672601 | chr7:27084425-27084426 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
37 | rs535290891 | chr7:27084428-27084429 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
38 | rs555482818 | chr7:27084457-27084458 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
39 | rs370871229 | chr7:27084458-27084459 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
40 | rs568845212 | chr7:27084512-27084513 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
41 | rs537876702 | chr7:27084553-27084554 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
42 | rs182199544 | chr7:27084581-27084582 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
43 | rs577185528 | chr7:27084582-27084583 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
44 | rs546098374 | chr7:27084592-27084593 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
45 | rs553204917 | chr7:27084593-27084594 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
46 | rs573141509 | chr7:27084599-27084600 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
47 | rs368150810 | chr7:27084614-27084615 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
48 | rs542040709 | chr7:27084616-27084617 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
49 | rs187136683 | chr7:27084648-27084649 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
50 | rs370385622 | chr7:27084712-27084713 | Weak transcription | Chromatin interactive region | 8 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Non-syndromic sensorineural hearing loss | 22570644 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung cancer | 17086460 | CNVD |
Breast cancer | 18852474 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:27081200-27086400 | Weak transcription | A549 | lung |
2 | chr7:27082200-27086200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr7:27086000-27086400 | Enhancers | HUVEC | blood vessel |
4 | chr7:27086000-27087400 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr7:27086200-27086400 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr7:27086200-27086400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr7:27086200-27086600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr7:27086200-27086600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
9 | chr7:27086200-27086600 | Enhancers | Osteobl | bone |
10 | chr7:27086200-27086800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr7:27086200-27086800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr7:27086200-27086800 | Enhancers | NHDF-Ad | bronchial |
13 | chr7:27086200-27087200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr7:27086200-27087200 | Enhancers | NHEK | skin |
15 | chr7:27086200-27087400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr7:27086200-27087400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr7:27086200-27087400 | Enhancers | Hela-S3 | cervix |
18 | chr7:27086200-27088200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |